TriSalus Life Sciences (TLSI) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts TLSI Hot Sheet
Join SI Premium – FREE
TriSalus Life Sciences (NASDAQ: TLSI) reported Q2 EPS of ($0.16), $0.01 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $11.41 million versus the consensus estimate of $10.79 million.
For earnings history and earnings-related data on TriSalus Life Sciences (TLSI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird Upgrades Titan Machinery (TITN) to Outperform
- Baird Upgrades AGCO Corporation (AGCO) to Outperform
- Guming Holdings (1364:HK) PT Raised to HK$28 at JPMorgan
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
